TGF-β1 was detected in 18 cases of III–IV stage ovarian cancer (85.71%), it was obviously higher than in I–II stage tumors (74.36%), but the disparity beween them was not significant (P>0.05). The gene discussed is TGFB1; the disease is ovarian carcinoma.